On July 1, 2022, the ST.26 standard entered into force, which dictates how biological sequence listings must be presented in patent applications.
To meet the sufficiency requirement in the description, inventions based on biological sequences (nucleic acids and proteins) must present, together with the description, a list in an electronic format that identifies in detail the sequences that are part of the invention.
This list also allows patent offices to search for the sequences of the invention in the databases to prepare search reports. Read more